Fortis Group Advisors, LLC

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1815183 WESTWOOD, NJ

Position in AXSM

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$270,470

+$84,548 QoQ

Shares Held

1,105

+0.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#380

of 500 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Fortis Group Advisors, LLC holds $498,707 across 4 Biotechnology names. AXSM ranks #1 (54.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc. This page	1,105	$270,470
2	LXRX	Lexicon Pharmaceuticals, Inc.	50,000	$120,000
3	PGEN	Precigen, Inc.	18,966	$108,106
4	CRBP	Corbus Pharmaceuticals Holdings, Inc.	14	$131

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$270,470	1,105	+0.5%	Shares	Sole	2026-07-24
2026-03-31	$185,922	1,100	0.0%	Shares	Sole	2026-05-08
2025-12-31	$200,904	1,100	—	Shares	Sole	2026-02-06
No filing history on record for this holder in this stock.